Plasma Calprotectin and New-onset Type 2 Diabetes in the General Population: A Prospective Cohort Study

Elevated plasma levels of calprotectin are associated with a higher risk of developing T2D in the general population and may represent a moveable inflammatory biomarker. This association, however, does not represent a direct effect, and seems dependent on hyperlipidemia and systemic inflammation.